Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H17NO4.ClH |
| Molecular Weight | 299.75 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.O=C(CN1CCOCC1)OCC(=O)C2=CC=CC=C2
InChI
InChIKey=PMRGOYRMDSBYKD-UHFFFAOYSA-N
InChI=1S/C14H17NO4.ClH/c16-13(12-4-2-1-3-5-12)11-19-14(17)10-15-6-8-18-9-7-15;/h1-5H,6-11H2;1H
DescriptionSources: Farmaco, Edizione Scientifica (1963), 18, (4), 245-53 | Endokrynologia Polska (1962), 13, 73-9.
Sources: Farmaco, Edizione Scientifica (1963), 18, (4), 245-53 | Endokrynologia Polska (1962), 13, 73-9.
Mobecarb is morpholineacetic acid derivative patented by Carlo Erba Societa per Azioni to prevent vascular rupture among persons afflicted with arterial hypertension. In preclinical models Mobecarb shows the capillary protective activity in partially omentectomized rats.
Originator
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID10204996
Created by
admin on Mon Mar 31 18:01:24 GMT 2025 , Edited by admin on Mon Mar 31 18:01:24 GMT 2025
|
PRIMARY | |||
|
4WMU8U315R
Created by
admin on Mon Mar 31 18:01:24 GMT 2025 , Edited by admin on Mon Mar 31 18:01:24 GMT 2025
|
PRIMARY | |||
|
56440-61-0
Created by
admin on Mon Mar 31 18:01:24 GMT 2025 , Edited by admin on Mon Mar 31 18:01:24 GMT 2025
|
PRIMARY | |||
|
71300932
Created by
admin on Mon Mar 31 18:01:24 GMT 2025 , Edited by admin on Mon Mar 31 18:01:24 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
